Correlation Between GlaxoSmithKline PLC and Blackrock Bal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Blackrock Bal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Blackrock Bal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Blackrock Bal Cap, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Blackrock Bal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Blackrock Bal. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Blackrock Bal.

Diversification Opportunities for GlaxoSmithKline PLC and Blackrock Bal

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Blackrock is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Blackrock Bal Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blackrock Bal Cap and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Blackrock Bal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blackrock Bal Cap has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Blackrock Bal go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Blackrock Bal

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 3.9 times less return on investment than Blackrock Bal. In addition to that, GlaxoSmithKline PLC is 2.35 times more volatile than Blackrock Bal Cap. It trades about 0.01 of its total potential returns per unit of risk. Blackrock Bal Cap is currently generating about 0.1 per unit of volatility. If you would invest  2,096  in Blackrock Bal Cap on August 30, 2024 and sell it today you would earn a total of  646.00  from holding Blackrock Bal Cap or generate 30.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Blackrock Bal Cap

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Blackrock Bal Cap 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Blackrock Bal Cap are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Blackrock Bal is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Blackrock Bal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Blackrock Bal

The main advantage of trading using opposite GlaxoSmithKline PLC and Blackrock Bal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Blackrock Bal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blackrock Bal will offset losses from the drop in Blackrock Bal's long position.
The idea behind GlaxoSmithKline PLC ADR and Blackrock Bal Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings